secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIODESIX INC (BDSX)
CIK:        0001439725
Form:       8-K
Filed at:   2024-05-23T23:59:59+00:00
Accession:  0001193125-24-145965
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biodesix shareholders elect three Class I directors and approve all proposals at 2024 annual meeting
--------------------------------------------------------------------------------

- Jon Faiz Kayyem, Scott Hutton, and John Patience elected as Class I directors with over 79M votes each.
- Ratification of KPMG as independent auditor for FY2024 approved (88.3M for, 167K against).
- Conversion of Series A Preferred Stock into common stock approved (82.4M for, 5.8K abstain).
- Issuance of Series A Preferred Stock to directors/officers approved (82.3M for, 437K against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1439725/000119312524145965/0001193125-24-145965-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1439725/000119312524145965/d832577d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-145965

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer